ArticleMetabolic brain disease2025
Rumex acetosa L. enhance learning and cognitive function by modulating NMDA receptor and BDNF pathways in vitro and in vivo.
Article in Metabolic brain disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dual-Omics Mapping of Tinnitus Phenotype Transition in Noise-Exposed Auditory Cortex.Cellular and molecular neurobiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rumex acetosa L. (RA), a member of the Polygonaceae family, is called sorrel and has been used as a vegetable and traditional medicine. RA has various bioactive functions; however, its effects on cognitive function remain unclear. Herein, we investigated the learning- and memory-enhancing effects of RA in rats using the Morris Water Maze (MWM) test. In addition, we evaluated the effect of RA on cognitive function in the hippocampus, both in vitro and in vivo, to identify the underlying molecular mechanisms. RA showed cognitive enhancing effects by activating cyclic AMP-responsive element-binding protein (CREB) via N-methyl-d-aspartate (NMDA) receptor 2 subunits (NR2A and NR2B), postsynaptic density protein-95 (PSD-95) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit (GluA1) signaling in primary cultured rat hippocampal neurons. For the in vivo experiments, RA was orally administered to SD rats for 26 days. RA showed significantly decreased escape latency on the first (acquisition) and last (retention) trials on the 2nd and 3rd training days and increased entry into the platform quadrant of time and distance on the probe trial. Furthermore, RA significantly increased NR2A, NR2B, PSD-95, and GluA1 the following downstream signaling extracellular signal-regulated kinase 1/2 (ERK1/2), calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylation, and brain-derived neurotrophic factor (BDNF) in the hippocampus. These results demonstrate that RA improves cognitive function, including synaptic plasticity, by regulating the NMDA receptor-dependent and BDNF/CREB signaling pathways.
Indexed as
Identifiers
40244509What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.